UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-In Capitol	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2020	$ 36	$ 115	$ (8,280)	$ 110,951	$ 102,822
Equity Balance, shares at Dec. 31, 2020	3,643
Common stock issued upon exercise of employee stock options	$ 0	787	0	0	787
Common stock issued upon exercise of employee stock options, shares	14
Common stock received and retired upon exercise of stock options	$ 0	(227)	0	0	(227)
Common stock received and retired upon exercise of stock options, shares	(2)
Stock option compensation expense	$ 0	166	0	0	166
Foreign currency translation adjustment	0	0	(773)	0	(773)
Common stock dividends	0	0	0	(10,425)	(10,425)
Net income	0	0	0	14,788	14,788
Equity Balance, value at Dec. 31, 2021	$ 36	842	(9,053)	115,314	107,138
Equity Balance, shares at Dec. 31, 2021	3,655
Common stock issued upon exercise of employee stock options	$ 0	211	0	0	211
Common stock issued upon exercise of employee stock options, shares	4
Common stock received and retired upon exercise of stock options	$ 0	(37)	0	0	(37)
Common stock received and retired upon exercise of stock options, shares	(1)
Stock option compensation expense	$ 0	183	0	0	183
Common stock purchased and retired	$ 0	(947)	0	(1,548)	(2,495)
Common stock purchased and retired, shares	(30)
Foreign currency translation adjustment	$ 0	0	(2,986)	0	(2,986)
Common stock dividends	0	0	0	(4,233)	(4,233)
Net income	0	0	0	16,473	16,473
Equity Balance, value at Dec. 31, 2022	$ 36	252	(12,039)	126,006	114,255
Equity Balance, shares at Dec. 31, 2022	3,628
Common stock issued upon exercise of employee stock options	$ 0	117	0	0	117
Common stock issued upon exercise of employee stock options, shares	2
Stock option compensation expense	$ 0	225	0	0	225
Foreign currency translation adjustment	0	0	1,381	0	1,381
Common stock dividends	0	0	0	(4,300)	(4,300)
Net income	0	0	0	16,635	16,635
Equity Balance, value at Dec. 31, 2023	$ 36	$ 594	$ (10,658)	$ 138,341	$ 128,313
Equity Balance, shares at Dec. 31, 2023	3,630